tradingkey.logo
tradingkey.logo
Search

Ascendis Pharma A/S

ASND
Add to Watchlist
243.910USD
-7.160-2.85%
Close 07-31 16:00ETQuotes delayed by 15 min
15.12BMarket Cap
35.15P/E TTM

ASND Financials

See Ascendis Pharma A/S's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Ascendis Pharma A/S Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
8.83/0.17
Revenue / Forecast
210.32M/229.26M
Period
FY2025 Earnings
Revenue(YoY)
854.80M
126.42%
EPS(YoY)
-4.42
34.64%
Analyst Rating
STRONG BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Financial Indicators
EPS
791.12%11.79
3.28%-0.64
38.64%-1.18
64.93%-0.72
31.41%-1.71
60.71%-0.67
37.00%-1.92
-3.21%-2.04
-36.29%-2.49
51.08%-1.70
---3.05
---1.98
---1.82
---3.46
---6.70
----
----
----
----
----
----
----
Revenue
153.66%289.14M
--208.51M
235.56%184.29M
315.63%135.49M
-0.00%89.41M
----
22.33%54.92M
-26.27%32.60M
193.53%89.41M
----
188.26%44.90M
639.01%44.21M
368.91%30.46M
387.41%21.46M
1506.20%15.58M
588.96%5.98M
961.66%6.50M
881.50%4.40M
-58.58%969.68K
-28.52%868.31K
-69.97%611.88K
-80.38%448.64K
Net Profit
790.64%737.90M
---28.27M
44.15%-52.61M
66.37%-33.31M
31.41%-83.81M
----
37.87%-94.21M
12.56%-99.05M
-21.47%-122.18M
----
11.90%-151.62M
-43.44%-113.28M
15.76%-100.58M
-103.87%-194.43M
-145.86%-172.10M
30.83%-78.97M
-131.83%-119.40M
18.16%-95.37M
32.28%-70.00M
-42.16%-114.17M
11.17%-51.50M
-58.96%-116.53M
Net Margin
372.27%255.21%
38.69%-13.56%
83.36%-28.55%
91.91%-24.58%
31.41%-93.73%
64.94%-22.12%
49.21%-171.52%
-18.59%-303.85%
58.62%-136.65%
93.04%-63.09%
---337.73%
---256.23%
---330.21%
---905.91%
---1328.86%
----
----
----
----
----
----
----
Gross Margin
12.40%92.90%
-1.60%90.47%
11.04%89.54%
17.54%80.10%
-10.27%82.65%
7.06%91.94%
-4.71%80.63%
-6.28%68.15%
6.80%92.11%
10.55%85.87%
--84.62%
--72.72%
--86.24%
--77.67%
--75.16%
----
----
----
----
----
----
----
Debt to assets ratio
-43.93%44.76%
-7.85%66.93%
-13.59%70.46%
-17.87%72.85%
-4.25%79.82%
-6.93%72.63%
6.94%81.55%
44.44%88.70%
59.39%83.37%
67.28%78.04%
--76.25%
--61.41%
--52.30%
--46.65%
--43.45%
----
----
----
----
----
----
----
Revenue
153.66%289.14M
--208.51M
235.56%184.29M
315.63%135.49M
-0.00%89.41M
----
22.33%54.92M
-26.27%32.60M
193.53%89.41M
----
188.26%44.90M
639.01%44.21M
368.91%30.46M
387.41%21.46M
1506.20%15.58M
588.96%5.98M
961.66%6.50M
881.50%4.40M
-58.58%969.68K
-28.52%868.31K
-69.97%611.88K
-80.38%448.64K
Operating profit
126.64%29.09M
--8.34M
110.33%9.49M
62.38%-45.39M
-86.91%-85.65M
----
26.87%-91.87M
8.15%-120.67M
64.83%-45.82M
----
14.66%-125.63M
4.66%-131.38M
-6.98%-130.30M
-36.47%-138.16M
-74.30%-147.20M
-37.88%-137.80M
-19.14%-121.80M
-26.22%-101.23M
-26.17%-84.45M
-42.43%-99.94M
-52.52%-102.24M
-35.58%-80.20M
Net Profit
790.64%737.90M
---28.27M
44.15%-52.61M
66.37%-33.31M
31.41%-83.81M
----
37.87%-94.21M
12.56%-99.05M
-21.47%-122.18M
----
11.90%-151.62M
-43.44%-113.28M
15.76%-100.58M
-103.87%-194.43M
-145.86%-172.10M
30.83%-78.97M
-131.83%-119.40M
18.16%-95.37M
32.28%-70.00M
-42.16%-114.17M
11.17%-51.50M
-58.96%-116.53M
Current assets
26.48%1.32B
--934.28M
-5.05%878.00M
43.81%816.94M
31.80%816.13M
----
34.99%924.73M
-10.14%568.07M
-15.69%619.22M
----
-37.73%685.04M
-41.47%632.16M
-31.14%734.42M
19.46%865.65M
31.99%1.10B
117.57%1.08B
89.21%1.07B
16.76%724.65M
2.93%833.41M
19.36%496.39M
11.61%563.71M
11.32%620.66M
Total current liabilities
32.14%1.32B
--900.92M
6.88%851.00M
4.41%801.54M
5.28%784.26M
----
300.41%796.26M
328.00%767.67M
314.13%744.96M
----
36.67%198.86M
60.42%179.36M
98.29%179.89M
644.56%671.89M
43.82%145.50M
87.19%111.81M
51.67%90.72M
103.79%90.24M
84.93%101.17M
29.86%59.73M
56.22%59.81M
1.15%44.28M
Total assets
95.99%2.35B
--1.10B
-4.10%996.16M
35.82%932.62M
25.64%940.07M
----
27.27%1.04B
-10.65%686.68M
-14.61%748.26M
----
-37.08%816.16M
-40.36%768.49M
-33.12%876.28M
4.71%1.02B
23.53%1.30B
78.04%1.29B
65.49%1.31B
18.73%975.56M
18.21%1.05B
52.61%723.75M
39.15%791.76M
33.09%821.63M
Total liabilities
25.76%1.78B
--1.23B
1.34%1.15B
11.86%1.09B
14.21%1.11B
----
27.84%1.13B
38.06%977.48M
33.90%970.33M
----
5.69%884.80M
1.40%708.01M
8.13%724.65M
327.99%774.64M
353.97%837.19M
400.02%698.25M
402.84%670.19M
52.99%181.00M
129.73%184.41M
97.78%139.64M
100.56%133.28M
62.89%118.31M
Total equity
366.97%572.15M
---137.17M
-62.48%-150.17M
44.71%-160.80M
24.30%-168.10M
----
-34.66%-92.42M
-580.78%-290.80M
-246.46%-222.08M
----
-114.92%-68.64M
-89.75%60.49M
-76.31%151.63M
-68.93%246.86M
-46.86%459.97M
1.06%590.31M
-2.79%640.11M
12.97%794.56M
7.13%865.62M
44.71%584.10M
31.03%658.48M
29.12%703.32M
Net operating income
43.98%-9.05M
--61.83M
103.48%1.86M
88.66%-6.29M
86.62%-12.68M
----
54.27%-53.31M
61.13%-55.52M
28.97%-94.72M
----
-15.79%-116.57M
-18.24%-142.84M
-7.17%-133.35M
-19.78%-132.81M
-18.50%-100.68M
-23.43%-120.81M
-85.87%-124.43M
-46.38%-110.88M
-73.06%-84.96M
-104.38%-97.88M
-9.47%-66.94M
-68.65%-75.75M
Net investment
-897.52%-7.92M
---2.86M
90.43%-45.72K
-775.44%-3.72M
-109.33%-622.62K
----
-102.30%-477.68K
-98.74%550.58K
-96.51%6.67M
----
44.61%20.77M
356.15%43.80M
420.96%191.03M
99.26%-747.09K
-19.30%14.36M
2.42%9.60M
248.44%36.67M
-68.72%-100.64M
-14.16%17.80M
104.65%9.38M
-339.30%-24.70M
-5691.65%-59.65M
Net financing
-112.21%-43.19M
--7.18M
-91.75%33.52M
369.20%5.98M
-192.93%-15.96M
----
203.26%406.34M
-3.21%-2.22M
2798.26%17.18M
----
173178.83%133.99M
0.77%-2.15M
-100.17%-636.62K
106.82%1.26M
-100.02%-77.42K
-283.66%-2.17M
2306619.21%378.40M
-314.47%-18.55M
-34.96%322.88M
-84.10%1.18M
101.60%16.40K
122.40%8.65M

FAQs

What is the total revenue of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its total revenue reached 854.80M, with a year-on-year change of 377.53M.

What are the current assets of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its current assets were 1.32B, with a year-on-year change of 19.52.

What are the total assets of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its total assets of Ascendis Pharma A/S were 1.55B, with a year-on-year change of 26.26.

What are the total liabilities of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its total liabilities of Ascendis Pharma A/S were 1.74B, with a year-on-year change of 30.36.

What is the total equity of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its total equity of Ascendis Pharma A/S was -193.27M, with a year-on-year change of -76.11.

What is the net operating income of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its net operating income of Ascendis Pharma A/S was -161.75M, with a year-on-year change of 44.11.

What is the net investment of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its net investment of Ascendis Pharma A/S was -10.07M, with a year-on-year change of -241.09.

What is the net financing of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its net financing of Ascendis Pharma A/S was 43.12M, with a year-on-year change of -90.64.

What is the Earnings Per Share (EPS) of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its Earnings Per Share (EPS) was -4.42, with a year-on-year change of 34.64.

What is the net income of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its net income was -270.68M, with a year-on-year change of 31.04.

What is the net margin of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its net profit margin was -31.67, with a year-on-year change of 69.54.

What is the gross margin of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its gross margin was 86.82, with a year-on-year change of -1.15.

What is the debt-to-asset ratio of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its debt-to-asset ratio was 66.93, with a year-on-year change of -7.85.

What is the Return on Assets (ROA) of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its Return on Assets (ROA) was -18.37, with a year-on-year change of 51.28.

What is the operating profit of Ascendis Pharma A/S?

According to Ascendis Pharma A/S's FY2025 earnings report, its operating profit was -161.75M, with a year-on-year change of 44.11.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.